GlassScriptPhysician profile
Thomas F Gregory
NPI 1174566624
$4,179.59
in general payments reported to CMS, 2019-2025
46 companies · $1,545 in 2025
The $1,545 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.21 · 2020: $134 · 2021: $221 · 2022: $478 · 2023: $564 · 2024: $1,194 · 2025: $1,545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,302.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $499.60 | 2021-2025 | Imjudo, Imfinzi, Enhertu |
| Tempus Ai, INC | $312.27 | 2024-2025 | Xt Cdx |
| Regeneron Healthcare Solutions, INC. | $302.61 | 2022-2025 | Libtayo, Lynozyfic |
| E.R. Squibb & Sons, L.L.C. | $290.30 | 2022-2025 | Opdivo |
| Abbvie INC. | $273.57 | 2020-2025 | |
| Glaxosmithkline, LLC. | $180.32 | 2021-2025 | Jemperli, Zejula, Blenrep |
| Pfizer INC. | $176.43 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $156.05 | 2020-2025 | Iclusig |
| Genzyme Corporation | $155.72 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $138.27 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $128.04 | 2022-2025 | |
| Daiichi Sankyo INC. | $97.34 | 2022-2025 | Enhertu, Vanflyta |
| Lilly USA, LLC | $95.20 | 2022-2025 | Verzenio, Jaypirca, Retevmo |
| Janssen Biotech, INC. | $94.44 | 2022-2025 | Tecvayli, Talvey |
| Sobi, INC | $92.18 | 2023-2024 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Gregory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.